RAPID MICRO BIOSYSTEMS INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
(a)Compensatory Arrangements of Certain Officers
On February 24, 2025, our board of directors approved the following additional bonus amounts granted at the discretion of the Board in excess of the amounts earned pursuant to predetermined performance objectives for the 2024 fiscal year: $100,534 for Robert Spignesi, President and Chief Executive Officer, $33,068 for Sean Wirtjes, Chief Financial Officer, and $33,068 for John Wilson, Chief Operating Officer. Each individual’s bonus was paid in cash on or about February 27, 2025.
(b)Director and Officer Trading Arrangements
None of our directors or officers adopted orterminated a Rule 10b5-1 trading arrangement, oradopted orterminated a non-Rule 10b5-1 trading arrangement (as defined in Item 408(c) of Regulation S-K) during the fourth quarter ended December 31, 2024.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.